About Concord Biotech
Concord Biotech is a company based in Ahmedabad (India) founded in 2000 by Ankur Vaid. The company has 1,570 employees as of March 31, 2024. Concord Biotech offers products and services including APIs, Formulations, and Contract Research and Manufacturing. Concord Biotech operates in a competitive market with competitors including Almac Group, Indoco Remedies, BDR Pharmaceuticals Internationals, Aurobindo Pharma and Asymchem, among others.
- Headquarter Ahmedabad, India
- Employees 1570 as on 31 Mar, 2024
- Founders Ankur Vaid
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Concord Biotech Ltd.
-
Annual Revenue
$138.12 M (USD)18.21as on Mar 31, 2025
-
Net Profit
$43.54 M (USD)20.62as on Mar 31, 2025
-
EBITDA
$58.06 M (USD)18.24as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Quadria Capital
& 2 more
-
Employee Count
1570
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Concord Biotech
Concord Biotech is a publicly listed company on the NSE with ticker symbol CONCORDBIO in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Concord Biotech
Concord Biotech offers a comprehensive portfolio of products and services, including APIs, Formulations, and Contract Research and Manufacturing.
Manufactures fermentation and semi-synthetic APIs for therapeutic segments.
Produces nephrology and critical care formulations for global markets.
Offers formulation development and manufacturing services for APIs.
People of Concord Biotech
Unlock access to complete
Funding Insights of Concord Biotech
Investors in Concord Biotech
Concord Biotech has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Quadria Capital, Helix Investments and Rakesh Jhunjhunwala.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Locked | Locked | Locked | |
|
Private equity firm focused on acquisitions
|
Locked | Locked | Locked | |
|
RJ
Rakesh Jhunjhunwala |
-
|
Locked | Locked | Locked |
Investor details for Concord Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concord Biotech
Investment portfolio details for Concord Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Concord Biotech
Detailed financials for Concord Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Concord Biotech Comparisons
Peer comparison for Concord Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Concord Biotech
Concord Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, BDR Pharmaceuticals Internationals, Aurobindo Pharma and Asymchem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Concord Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Concord Biotech
Complete news archive for Concord Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concord Biotech
Concord Biotech was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Concord Biotech is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
As of Mar 31, 2024, the latest employee count at Concord Biotech is 1,570.
Annual revenue of Concord Biotech is $138.12M as on Mar 31, 2025.
Founded in 2000 in Ahmedabad, India, the company operates as a CDMO in the pharmaceutical sector, specializing in research and production of fermentation-based semi-synthetic and synthetic APIs. Products cover immunosuppressants, antibiotics, oncology, antifungals, hypolipidemics, and enzymes. Services include strain improvement and contract fermentation manufacturing. Capabilities extend to solid orals, oral liquids, and suspensions compliant with global standards, with supplies provided internationally.
Concord Biotech's top competitors include BDR Pharmaceuticals Internationals, Almac Group and Indoco Remedies.
Concord Biotech offers APIs, Formulations, and Contract Research and Manufacturing.
Yes, Concord Biotech is publicly traded on NSE under the ticker symbol CONCORDBIO.
Concord Biotech has 3 investors. Key investors include Quadria Capital, Helix Investments, and Rakesh Jhunjhunwala.
The ticker symbol of Concord Biotech is CONCORDBIO on NSE.
The valuation of Concord Biotech is $352.41M as of Jul 2016.